Investments, Funding & Disinvestment

Everest Medicines plans to deliver predictable near-term value through commercializing existing assets, forming business development partnerships, and achieving in-house research and development milestones.

Through this acquisition, Philips aims to enhance the precision and efficiency of coronary interventions, ultimately benefiting both healthcare professionals and patients.

These investments will focus primarily on companies developing breakthrough technologies in gastrointestinal (GI), urology, and respiratory care.

The Alabama site is part of Lilly’s USD 27 billion U.S. onshoring initiative, aimed at reinforcing domestic pharmaceutical manufacturing.

YaoPharma stands to earn as much as USD1.94 billion in additional milestone payments tied to development, regulatory, and commercial achievements.

This substantial investment will enable the company to expand its distribution capacity for essential medical equipment and consumables across Senegal’s healthcare sector.

The launch represents a significant advancement in precision oncology, offering new hope to patients who previously had limited treatment options.

The Lions Hope Center represents a collaborative effort between Kenyatta National Hospital, the Lions Clubs International Foundation (LCIF), and the Kasigau Students Education Fund (KSEF).

The agreement outlines a comprehensive plan to save lives, build a more resilient health system, and enhance both nations’ capacity to address emerging global health challenges.